http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107519188-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7008 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K41-0038 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7008 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K41-00 |
| filingDate | 2017-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-08-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-08-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-107519188-B |
| titleOfInvention | Gucosamine is preparing the application in radiotherapy hypersitization medicine |
| abstract | The present invention relates to drug fields, the specifically new application of gucosamine, that is, are preparing the application in radiotherapy hypersitization medicine, the structural formula of the gucosamine is as follows.Gucosamine of the present invention can be used for preparing radio sensitization medicine, and can be under the concentration having no toxic side effect, hence it is evident that increase the radiation sensitivity of lung carcinoma cell. |
| priorityDate | 2017-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 40.